Private Trust Co. NA Buys 2,410 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Private Trust Co. NA grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 476.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,916 shares of the exchange traded fund’s stock after acquiring an additional 2,410 shares during the quarter. Private Trust Co. NA’s holdings in SPDR S&P Biotech ETF were worth $288,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of XBI. Hartline Investment Corp grew its stake in SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after acquiring an additional 106 shares during the period. Intellectus Partners LLC grew its position in shares of SPDR S&P Biotech ETF by 1.0% in the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock valued at $1,051,000 after purchasing an additional 113 shares during the period. Signature Estate & Investment Advisors LLC increased its stake in SPDR S&P Biotech ETF by 5.7% during the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after purchasing an additional 125 shares in the last quarter. Denver Wealth Management Inc. raised its holdings in SPDR S&P Biotech ETF by 0.9% during the 3rd quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after buying an additional 127 shares during the period. Finally, Bourgeon Capital Management LLC lifted its stake in SPDR S&P Biotech ETF by 5.9% in the second quarter. Bourgeon Capital Management LLC now owns 2,427 shares of the exchange traded fund’s stock valued at $225,000 after buying an additional 135 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 1.2 %

SPDR S&P Biotech ETF stock opened at $100.00 on Friday. SPDR S&P Biotech ETF has a twelve month low of $72.10 and a twelve month high of $105.47. The company has a 50 day moving average of $98.31 and a 200-day moving average of $96.48. The stock has a market capitalization of $7.62 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.